Anticoagulation for emergency department patients with atrial fibrillation: Is our duty to inform or prescribe?

Annals of Emergency Medicine

Volumn 62, Issue 6, 2013, Pages 566-568

  Barrett, Tyler W ^a   Marill, Keith A ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; APIXABAN; CLOPIDOGREL; DABIGATRAN; LOW MOLECULAR WEIGHT HEPARIN; RIVAROXABAN; WARFARIN;

ANTICOAGULANT THERAPY; CHADS2 SCORE; DEEP VEIN THROMBOSIS; DRUG MONITORING; EMBOLISM PREVENTION; EMERGENCY HEALTH SERVICE; EMERGENCY PHYSICIAN; EMERGENCY WARD; HEART ATRIUM FIBRILLATION; HUMAN; PATIENT PREFERENCE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; TREATMENT DURATION;

EID: 84888132459     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2013.05.027     Document Type: Editorial

References (21)

1. F.X. Scheuermeyer Missed opportunities for appropriate anticoagulation among emergency department patients with uncomplicated atrial fibrillation or flutter Ann Emerg Med 62 2013 557 565
2. T.W. Barrett, A.R. Martin, and A.B. Storrow A clinical prediction model to estimate risk for 30-day adverse events in emergency department patients with symptomatic atrial fibrillation Ann Emerg Med 57 2011 1 12
3. F.X. Scheuermeyer, E. Grafstein, and R. Stenstrom Thirty-day and 1-year outcomes of emergency department patients with atrial fibrillation and no acute underlying medical cause Ann Emerg Med 60 2012 755 765
4. I.G. Stiell, C.M. Clement, and R.J. Brison Variation in management of recent-onset atrial fibrillation and flutter among academic hospital emergency departments Ann Emerg Med 57 2011 13 21
5. A.J. McDonald, A.J. Pelletier, and P.T. Ellinor Increasing US emergency department visit rates and subsequent hospital admissions for atrial fibrillation from 1993 to 2004 Ann Emerg Med 51 2008 58 65
6. T.W.S.W. Barrett, C.A. Jenkins, and B.S. Heavrin Emergency department visits for atrial fibrillation between 2006 and 2009: regional variability in hospitalization and cardioversion Acad Emerg Med 20 2013 S136
7. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation: a major contributor to stroke in the elderly The Framingham Study Arch Intern Med 147 1987 1561 1564
8. J.L. Anderson, J.L. Halperin, and N.M. Albert Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 61 2013 1935 1944
9. V. Fuster, L.E. Ryden, and D.S. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) J Am Coll Cardiol 48 2006 854 906
10. A.J. Camm, G.Y. Lip, and R. De Caterina 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation Developed with the special contribution of the European Heart Rhythm Association Eur Heart J 33 2012 2719 2747
11. B.F. Gage, C. van Walraven, and L. Pearce Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin Circulation 110 2004 2287 2292
12. B.F. Gage, A.D. Waterman, and W. Shannon Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
13. F.D. Hobbs, A.K. Roalfe, and G.Y. Lip Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial BMJ 342 2011 d3653
14. M. Coppens, J.W. Eikelboom, and R.G. Hart The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy Eur Heart J 34 2013 170 176
15. R. Pisters, D.A. Lane, and R. Nieuwlaat A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey Chest 138 2010 1093 1100
16. R.G. Hart, L.A. Pearce, and M.I. Aguilar Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 146 2007 857 867
17. T.W.A.R. Barrett, A.B. Storrow, and C.A. Jenkins Incidence of 5 and 30 day adverse events in emergency department patients with symptomatic atrial fibrillation and atrial flutter Heart Rhythm 10 2013 S308
18. B. Coll-Vinent, C. Fuenzalida, and A. Garcia Management of acute atrial fibrillation in the emergency department: a systematic review of recent studies Eur J Emerg Med 20 2013 151 159
19. C. Rogenstein, A.M. Kelly, and S. Mason An international view of how recent-onset atrial fibrillation is treated in the emergency department Acad Emerg Med 19 2012 1255 1260
20. B.G. Cohn, S.M. Keim, and D.M. Yealy Is emergency department cardioversion of recent-onset atrial fibrillation safe and effective? J Emerg Med 45 2013 117 127
21. C.L. Atzema, P.C. Austin, and A.S. Chong Factors associated with 90-day death after emergency department discharge for atrial fibrillation Ann Emerg Med 61 2013 539 548.e1